# Head to Head Study Against Sevelamer Hydrochloride

> **NCT00441545** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 182 (actual)

## Conditions studied

- Chronic Kidney Disease, Stage 5

## Interventions

- **DRUG:** Fosrenol (Lanthanum Carbonate)
- **DRUG:** Sevelamer hydrochloride

## Key facts

- **NCT ID:** NCT00441545
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01-05
- **Primary completion:** 2008-07-31
- **Final completion:** 2008-07-31
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00441545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00441545, "Head to Head Study Against Sevelamer Hydrochloride". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00441545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*